Seliem, WA, Falk, MC, Shadbolt, B, Kent, AL. Antenatal and postnatal risk factors for neonatal hypertension and infant follow-up. Pediatr Nephrol
2007; 22: 2081–2087.
Alagappan, A, Malloy, MH. Systemic hypertension in very low-birth weight infants with bronchopulmonary dysplasia: incidence and risk factors. Am J Perinatol
1998; 15: 3–8.
Dionne, JM, Abitbol, CL, Flynn, JT. Hypertension in infancy: diagnosis, management and outcome. Pediatr Nephrol
2012; 27: 17–32.
Blowey, DL, Duda, PJ, Stokes, P, Hall, M. Incidence and treatment of hypertension in the neonatal intensive care unit. J Am Soc Hypertens
2011; 5: 478–483.
Sahu, R, Pannu, H, Yu, R, Shete, S, Bricker, JT, Gupta-Malhotra, M. Systemic hypertension requiring treatment in the neonatal intensive care unit. J Pediatr
2013; 163: 84–88.
Hsieh, EM, Hornik, CP, Clark, RH, et al. Medication use in the neonatal intensive care unit. Am J Perinatol
2014; 31: 811–822.
Singh, HP, Hurley, RM, Myers, TF. Neonatal hypertension. Incidence and risk factors. Am J Hypertens
1992; 5: 51–55.
Buchi, KF, Siegler, RL. Hypertension in the first month of life. J Hypertens
1986; 4: 525–528.
Skalina, ME, Kliegman, RM, Fanaroff, AA. Epidemiology and management of severe symptomatic neonatal hypertension. Am J Perinatol
1986; 3: 235–239.
American Academy of Pediatrics Committee on Fetus and Newborn: routine evaluation of blood pressure, hematocrit, and glucose in newborns. Pediatrics
1993; 92: 474–476.
de Swiet, M, Fayers, P, Shinebourne, EA. Systolic blood pressure in a population of infants in the first year of life: the Brompton study. Pediatrics
1980; 65: 1028–1035.
Pejovic, B, Peco-Antic, A, Marinkovic-Eric, J. Blood pressure in non-critically ill preterm and full-term neonates. Pediatr Nephrol
2006; 22: 249–257.
Kent, AL, Meskell, S, Falk, MC, Shadbolt, B. Normative blood pressure data in non-ventilated premature neonates from 28–36 weeks gestation. Pediatr Nephrol
2008; 24: 141–146.
Lurbe, E, Garcia-Vicent, C, Torro, I, et al. First-year blood pressure increase steepest in low birthweight newborns. J Hypertens
2006; 25: 81–86.
Zubrow, AB, Hulman, S, Kushner, H, Falkner, B. Determinants of blood pressure in infants admitted to neonatal intensive care units: a prospective multicenter study. Philadelphia Neonatal Blood Pressure Study Group. J Perinatol
1995; 15: 470–479.
Friedman, AL, Hustead, VA. Hypertension in babies following discharge from a neonatal intensive care unit. A 3-year follow-up. Pediatr Nephrol
1987; 1: 30–34.
O’Dea, RF, Mirkin, BL, Alward, CT, Sinaiko, AR. Treatment of neonatal hypertension with captopril. J Pediatr
1988; 113: 403–406.
Guron, G, Friberg, P. An intact renin-angiotensin system is a prerequisite for normal renal development. J Hypertens
2000; 18: 123–137.
Wells, TG, Bunchman, TE, Kearns, GL. Treatment of neonatal hypertension with enalaprilat. J Pediatr
1990; 117: 664–667.
Mason, T, Polak, MJ, Pyles, L, Mullett, M, Swanke, C. Treatment of neonatal renovascular hypertension with intravenous enalapril. Am J Perinatol
1992; 9: 254–257.
Flynn, JT. Neonatal hypertension: diagnosis and management. Pediatr Nephrol
2000; 14: 332–341.
Sheftel, DN, Hustead, V, Friedman, A. Hypertension screening in the follow-up of premature infants. Pediatrics
1983; 71: 763–766.
Arar, MY, Hogg, RJ, Arant, BS, Seikaly, MG. Etiology of sustained hypertension in children in the southwestern United States. Pediatr Nephrol
1994; 8: 186–189.
Shah, AB, Hashmi, S, Sahulee, R, Pannu, H, Gupta-Malhotra, M. Characteristics of systemic hypertension in preterm children. J Clin Hypertens (Greenwich)
2015; 17: 364–370.
Chu, PY, Hill, KD, Clark, RH, Smith, PB, Hornik, CP. Treatment of supraventricular tachycardia in infants: analysis of a large multicenter database. Early Hum Dev
2015; 91: 345–350.
Hsu, DT, Zak, V, Mahony, L, et al. Enalapril in infants with single ventricle: results of a multicenter randomized trial. Circulation
2010; 122: 333–340.